Author

S. Bashi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:experimental assay· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

A. F. Pinto· 1 shared A. R. Atkins· 1 shared C. E. Antal· 1 shared C. Fraser· 1 shared C. Liddle· 1 shared D. C. Nelson· 1 shared D. D. Von Hoff· 1 shared D. Engle· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. F. Pinto

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Inhibiting Stromal Class I HDACs Curbs Pancreatic Cancer Progression

G. Liang, T. G. Oh, N. Hah, H. Tiriac, Y. Shi, M. L. Truitt, C. E. Antal, A. R. Atkins, Y. Li, C. Fraser, S. Ng, A. F. Pinto, D. C. Nelson, S. Bashi, E. Banayo, , R. M. Evans

This study shows that inhibiting stromal Class I HDACs reduces pancreatic cancer progression by targeting desmoplastic and pro-tumorigenic programs in cancer-associated fibroblasts.

Nature Communications · Dec 6, 2023Peer-reviewedCancer Biology